; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (169) Mixtures of at least 95 percent by weight allyl isothiocyanate and application adjuvants Heading 9902.09.75 is amended— (A) by amending the article description to read as follows: Mixtures of at least 95 percent by weight allyl isothiocyanate (3-isothiocyanato-1-propene) (CAS No. 57–06–7), and application adjuvants (provided for in subheading 3808.92.28) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (170) Polyoxin D zinc salt Heading 9902.09.79 is amended— (A) by amending the article description to read as follows: Formulations of zinc 1-{(2R,3R,4S,5R)-5-[(S)-{[(2S,3S,4S)-2-amino-5-carbamoyloxy)-3,4-dihydroxypentanoyl] amino}(carboxylato)methyl]-3,4-dihydroxytetrahydro-2-furanyl}-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate (Polyoxin D zinc salt) (CAS No. 146659–78–1) (provided for in subheading 3808.92.50) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (171) Foramsulfuron formulations Heading 9902.09.87 is amended— (A) by amending the article description to read as follows: Mixtures of 2-[[[[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl]amino]sulfonyl]-4-(formylamino)-N,N-dimethylbenzamide (Foramsulfuron) (CAS No. 173159–57–4) and application adjuvants (provided for in subheading 3808.93.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (172) Indaziflam and rimsulfuron formulations Heading 9902.09.90 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-yl]-6-[(1R)-1-fluoroethyl] -1,3,5-triazine-2,4-diamine (Indaziflam) (CAS No. 950782–86–2) and N-[(4,6-dimethoxy-2-pyrimidinyl) carbamoyl] -3-(ethylsulfonyl)-2-pyridinesulfonamide (Rimsulfuron) (CAS No. 122931–48–0) (provided for in subheading 3808.93.15)